Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading

1
HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy
1:03:10
1:03:10
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:03:10Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes data presented at the recent 2024 San Antonio Breast Cancer Symposium applicable to the management of HR-positive breast cancer. CME information and select publications here.Research To Practice による
…
continue reading

1
Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses
1:05:16
1:05:16
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:05:16Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma. NCPD information and select publications here.Research To Practice による
…
continue reading

1
5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
16:10
16:10
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
16:10Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.Research To Practice による
…
continue reading

1
Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel
49:28
49:28
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
49:28Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1. CME information and select publications here.Research To Practice による
…
continue reading

1
Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses
1:05:59
1:05:59
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:05:59Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma. NCPD information and select publications here.Research To Practice による
…
continue reading